EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.889
https://www.valueinhealthjournal.com/article/S1098-3015(22)01090-7/fulltext
Title : EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01090-7&doi=10.1016/j.jval.2022.04.889
First page :
Section Title :
Open access? : No
Section Order : 10807
Categories :
Tags :
Regions :
ViH Article Tags :